Opdivosafetytool.com
Visit opdivosafetytool.com-
11 months ago
Last scanned
-
7 years
Domain Age
-
No data
Daily Visitors
-
No data
Global Rank
Opdivosafetytool.com
Visit opdivosafetytool.com
About Website
Updated:
Treatment Modifications | OPDIVO® (nivolumab)
Find recommendations about treatment modifications to manage adverse reactions in OPDIVO® (nivolumab) patients. Please see Indications and Important Safety Information.
Network Data
This website is hosted with Salesforce.com, Inc., which reserves the following IP addresses for opdivosafetytool.com: 13.110.24.10, 13.110.24.11, 13.110.24.13. Moreover, DNS used with this website include ns1.bms.com, ns2.bms.com, ns3.bms.com, ns4.bms.com. Subnet identifier ranges from 13.108.0.0 to 13.111.255.255. Classless Inter-Domain Routing (CIDR) is 13.108.0.0/14. ARIN net type is Direct Allocation.
-
11 months ago
Last scanned
-
7 years
Domain Age
-
No data
Daily Visitors
-
No data
Global Rank
Network
ADDRESSING DETAILS
-
Hosting Company
-
IPs
-
DNS
ns1.bms.com
ns2.bms.com
ns3.bms.com
ns4.bms.com
Whois
OWNERSHIP
-
Created
2016-09-16
-
Expires
2023-09-16
-
Owner
-
Registar
CSC CORPORATE DOMAINS, INC.
-
Owner Emails
Domain & Keywords
The registrar of opdivosafetytool.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2023-09-16. According to open source data, you can reach the owner at dns.admin@BMS.COM but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.
- CHL
- metastatic melanoma
- rcc
- nsclc
- imar
- non small cell lung cancer
- advanced renal cell carcinoma
- nivolumab
- opdivo
- opdivo prescribing information
Websites similar to opdivosafetytool.com
-
opdivo.com-
Global rank
618K
-
Daily Visitors
534
-
-
opdivohcp.com-
Global rank
N/A
-
Daily Visitors
N/A
-
-
navyanetwork.com-
Global rank
N/A
-
Daily Visitors
N/A
-
-
sicheng.net-
Global rank
N/A
-
Daily Visitors
N/A
-
-
pharmastrategyblog.com-
Global rank
N/A
-
Daily Visitors
N/A
-